UK Life Sciences Company Directory

Colour-changing biochemical swabs for rapid contamination screening

FreshCheck develops patented colour-changing biochemical swabs for rapid verification of surface hygiene in food production and other facilities. Its Hygiene Verification System detects residual microbial and organic contamination, delivering a visual result within seconds without laboratory instrumentation. A…

AAV gene therapies for neurodegenerative diseases including FTD and ALS

AviadoBio is a clinical-stage gene therapy company developing AAV-based treatments for neurodegenerative diseases. Its lead programme, AVB-101, is in a Phase 1/2 trial for frontotemporal dementia caused by GRN gene mutations, delivering a functional copy of the GRN gene via intrathalamic infusion to restore…

In silico software and AI for small molecule drug discovery

Optibrium is a software company providing integrated computational platforms for small molecule design, optimisation and data analysis across preclinical drug discovery. Its tools support compound property prediction, multi-parameter optimisation, AI-driven data analysis, de novo design, and structure-based modelling,…

Blood-based CIZ1B biomarker test for early-stage lung cancer detection

Cizzle Biotechnology is a UK-based diagnostics company developing a non-invasive blood test for the early detection of lung cancer. The company's CIZ1B biomarker test identifies a stable plasma biomarker highly correlated with early-stage disease, offering an alternative to imaging or biopsy procedures. Cizzle's test…

Cocrystal drug repurposing for oncology supportive care and fibrosis

Nuformix is a pharmaceutical development company using proprietary cocrystal technology to repurpose existing drugs for unmet medical needs in fibrosis and oncology. By reengineering a drug's crystal form, the company improves properties such as dissolution and absorption, creating differentiated, patentable products…

Imperial College's life sciences and deep tech innovation district

White City Innovation District is a multi-sector innovation district in West London, formed through a partnership between Imperial College London and the London Borough of Hammersmith and Fulham. Anchored by Imperial's White City Deep Tech Campus, it is home to over 100 companies spanning life sciences, AI, deep tech,…

Single-cell omics analysis platform for precision neuroscience research

CellClar is a UK-based Community Interest Company developing an AI-assisted software platform for single-cell omics data analysis in precision medicine. Its flagship product is designed to transform complex single-cell sequencing datasets into actionable insights for researchers working on neurodegenerative diseases,…

AI operating system connecting pharma drug development decisions end-to-end

Perceptic is a UK software company that has built an AI platform connecting decision-making across the drug development lifecycle. Its system unifies external asset scouting, scientific evaluation of licensing candidates, indication selection for clinical trials, and clinical data analysis within a single, traceable…

National facility for mouse genetics and preclinical disease modelling

The Mary Lyon Centre at MRC Harwell is the UK's national centre for mouse genetics, providing mouse model generation, phenotyping, cryopreservation, and archiving services to academic and industry researchers worldwide. The Centre offers genome engineering using CRISPR and other techniques to create genetically…

RNA immunotherapies targeting novel tumour-specific antigens

Epitopea is a biopharma company developing off-the-shelf RNA-based immunotherapies for hard-to-treat cancers. Using spatial immunopeptidomics, genomics, and systems bioinformatics, the company identifies aberrantly-expressed tumour-specific antigens that are broadly shared across patients with the same tumour type.…

Mitochondrial DNA liquid biopsy tests for cancer and disease detection

MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers. Its technology detects specific mitochondrial DNA deletions in blood and tissue samples as indicators of disease, enabling non-invasive testing for conditions that are difficult to diagnose.…

Anti-cancer drug formulation and manufacturing technology development services

PTC Oncology is a contract research organisation specialising in the formulation and manufacturing technology development of anti-cancer drugs. The company supports pharmaceutical manufacturers, research centres, and academic institutions with pre-formulation studies, process design, scale-up, and analytical method…

Infant gut bacteria-derived therapeutic compounds

Bioscopic is a UK biotech developing therapeutic compounds derived from infant gut bacteria to treat cancer and chronic disease. It holds what it describes as the world's largest collection of infant gut bacterial strains, which it uses as a screening platform to identify biologically active compounds. Its lead…

Preclinical and clinical CRO specialising in biomarker services

Epistem is a contract research organisation providing preclinical and clinical research services to pharmaceutical and biotechnology companies. Its capabilities span in vivo and in vitro preclinical models across oncology, gastrointestinal disease, dermatology, and autoimmune indications, alongside GCLP-accredited…

Lab-on-PCB biosensors for non-invasive point-of-care diagnostics

TeslaDiagnostiX develops miniaturised electrochemical diagnostic systems using lab-on-printed-circuit-board technology for biological sample testing. Its lead programme is a quantitative saliva glucose assay intended to provide a non-invasive alternative to blood-based measurement. The device combines disposable PCB…

Full-service CRO specialising in oncology and rare diseases

Simbec-Orion is a full-service CRO providing Phase I to Phase IV clinical trial services, with specialist expertise in oncology, rare and orphan diseases, and clinical pharmacology. Its Merthyr Tydfil campus houses a 58-bed MHRA-accredited Phase I unit, Seirian Laboratories for central pathology and bioanalysis, IMP…

Global crop protection, seed and digital agriculture solutions provider

Corteva Agriscience UK is the British operating subsidiary of Corteva, Inc., a global agriculture company formed from the DuPont Pioneer, Dow AgroSciences and DuPont Crop Protection businesses. The company supplies Pioneer and Brevant seed varieties, crop protection products including herbicides, insecticides and…

Science and innovation campus in Oxford's Cowley district

ARC Oxford is an 88-acre science and innovation campus located in Cowley, Oxford, operating as part of the Advanced Research Clusters network owned by Brookfield. Formerly Oxford Business Park, it was relaunched under the ARC brand in September 2022. The campus hosts over 35 organisations including a growing number of…

Therapeutic cancer vaccines based on recombinant overlapping peptide technology

Oxford Vacmedix is a clinical-stage biopharma company developing therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform. ROPs stimulate broad T cell and antibody immunity without HLA restriction, enabling a universal immunotherapy approach. The lead programme, OVM-200, targets…

Predictive genetic tests for cancer and cardiovascular disease

GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked molecular tests for coronary artery disease, familial hypercholesterolaemia and thrombosis risk, alongside the ROCA test for ovarian cancer…